Dr. Kristina Deligiannidis is the Director of Women’s Behavioral Health at Zucker Hillside Hospital, Northwell Health and a Professor of Psychiatry, Molecular Medicine and Obstetrics and Gynecology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in New York. As Director, she leads a clinical/translational research program and advises on policies and services promoting women’s behavioral health at Northwell Health in metro New York. Dr. Deligiannidis additionally serves as the Medical Director for Reproductive Psychiatry for the perinatal psychiatry access program, Project TEACH, funded by the New York State Office of Mental Health. For Project TEACH, Dr. Deligiannidis leads a team of reproductive psychiatrists/psychologists to provide education and phone consultation to maternal health clinicians on perinatal mood and anxiety disorders, across all 62 counties of New York. As a reproductive psychiatrist, she has expertise in treating women with mood and anxiety disorders linked to the menstrual cycle, perinatal and perimenopausal periods.

Dr. Deligiannidis is a nationally recognized leader in the field of perinatal depression and in novel therapeutics research. Her research program includes a focus in psychoneuroendocrinology, particularly neurosteroids and hormones, and multimodal neuroimaging in women’s behavioral health. Dr. Deligiannidis’s research is supported by NIH R01, foundation and industry funding. Her efforts have been nationally recognized with many awards for research and medical student and resident teaching. She has published numerous peer-reviewed manuscripts and has given over 200 oral presentations/research posters at local, national and international scientific conferences. Her recent publications have been in high impact journals including the Lancet, Lancet Psychiatry, JAMA Psychiatry, American Journal of Psychiatry, Neuropsychopharmacology and Molecular Psychiatry. Her research has been covered by major media outlets (>100 interviews in the past few years), including CNN, the Associated Press, NPR All Things Considered, NPR 1A, the Boston Globe, CBS Sunday Morning, the Canadian Broadcasting Company, the Wall Street Journal, Time Magazine, Good Morning America and others.

Dr. Deligiannidis actively contributes to national scientific committees and gives scientific presentations nationally and internationally. She is a current Board of Directors member and President Elect for the Marcé of North America, past Council member of the Society of Biological Psychiatry, past Board of Directors member for the American Society of Clinical Psychopharmacology and currently is a full member of the American College of Neuropsychopharmacology. Dr. Deligiannidis also serves as a reviewer on over 20 scientific journals and on Editorial Boards of national and international journals. She serves as a federal grant reviewer for the Center for Scientific Review at NIH.

Locally in New York, she serves on steering committees in both the Departments of Obstetrics & Gynecology and Psychiatry at Long Island Jewish Medical Center and Zucker Hillside Hospital and at the Katz Institute for Women’s Health on Long Island. She additionally served for 7 years on Faculty Council and currently serves on the Zucker Women in Medicine and Science Gender and Equity Committee at the Zucker School of Medicine at Hofstra/Northwell. She is a sought-out educator and mentor to medical students, residents, fellows and faculty across Northwell Health and at its School of Medicine.

Dr. Deligiannidis received her medical degree from and completed her psychiatry residency and chief residency in psychopharmacology research at the University of Massachusetts Medical School (2009). Prior to and during medical school she trained in neuroscience research at the National Institutes of Health. After residency she completed additional research training in behavioral endocrinology and experimental therapeutics at the NIH and in neuroimaging at the Martinos Center for Biomedical Imaging at Massachusetts General Hospital.